We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Novel Surgical Mesh Repairs Soft Tissues

By HospiMedica staff writers
Posted on 25 Apr 2007
A new surgical mesh offers a significant reduction in both foreign body reaction and inflammation, promoting a well healed, reinforced soft tissue repair.

The C-QURLite mesh combines a polypropylene mesh with a pharmaceutical grade Omega 3 fatty acid bio-absorbable (BA) gel coating, and is indicated for use in the surgical repair and reinforcement of soft tissue, including hernia repair. More...
The mesh is constructed from ProLite Ultra polypropylene monofilament, providing a low profile, strong, lightweight base structure. The all natural Omega 3 gel coating is then applied, coating each monofilament of the mesh to enhance material handling and subsequent healing. Pre-clinical studies have demonstrated that combining inert thin wall polypropylene mesh with an Omega 3 biological coating results in minimization of peritoneal tissue attachment and significantly improve anatomical conformance by reducing aggressive, dense acellular collagen formation known to induce adhesions following surgery.

The BA coating also enhances ease of handling and tissue plane placement, which subsequently forms into a soft and flexible implant. Improved stiffness and handling qualities and excellent see-thru visibility to underlying tissue landmarks provide improved anatomical orientation during surgical installation. The C-QURLite mesh, a product of Atrium Medical (Hudson, NH, USA) has been approved by the U.S. Food and Drug Administration (FDA), and will be available in a wide variety of preferred anatomical laser cut shapes and sizes mid-year 2007.


Related Links:
Atrium Medical

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.